0000899243-20-019461.txt : 20200716
0000899243-20-019461.hdr.sgml : 20200716
20200716203613
ACCESSION NUMBER: 0000899243-20-019461
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200716
FILED AS OF DATE: 20200716
DATE AS OF CHANGE: 20200716
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROCHE HOLDING LTD
CENTRAL INDEX KEY: 0000889131
STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 8880 [8880]
STATE OF INCORPORATION: V8
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39381
FILM NUMBER: 201032569
BUSINESS ADDRESS:
STREET 1: ROCHE HOLDING, LTD.
STREET 2: GRENZACHERSTRASSE 124
CITY: BASEL
STATE: V8
ZIP: CH-4070
BUSINESS PHONE: 9732354295
MAIL ADDRESS:
STREET 1: ROCHE HOLDING, LTD.
STREET 2: GRENZACHERSTRASSE 124
CITY: BASEL
STATE: V8
ZIP: CH-4070
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROCHE FINANCE LTD
CENTRAL INDEX KEY: 0001053942
STATE OF INCORPORATION: V8
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39381
FILM NUMBER: 201032570
BUSINESS ADDRESS:
STREET 1: C/O HOFFMAN LA ROCHE
STREET 2: 124 GRENSACHERSTRASSE CH 4002
CITY: BASEL SWITZERLAND
STATE: V8
MAIL ADDRESS:
STREET 1: C/O HOFFMAN LA ROCHE
STREET 2: 124 GRENSACHERSTRASSE CH 4002
CITY: BASEL SWITZERLAND
STATE: V8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pandion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001807901
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 833015614
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 134 COOLIDGE AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-393-5925
MAIL ADDRESS:
STREET 1: 134 COOLIDGE AVENUE
STREET 2: 2ND FLOOR
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Pandion Therapeutics Holdco LLC
DATE OF NAME CHANGE: 20200327
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-07-16
0
0001807901
Pandion Therapeutics, Inc.
PAND
0000889131
ROCHE HOLDING LTD
GRENZACHERSTRASSE 124, 4070
BASEL
V8
SWITZERLAND
0
0
1
0
0001053942
ROCHE FINANCE LTD
GRENZACHERSTRASSE 124,4058
BASEL
V8
SWITZERLAND
0
0
1
0
Series A Preferred Stock
Common Stock
2576564
I
See footnote
Series B Preferred Stock
Common Stock
473409
I
See footnote
The Series A Preferred Stock is convertible into Common Stock on a 5.0994-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
Roche Finance Ltd ("Roche Finance") is the direct beneficial owner of these securities of the Issuer. Roche Finance is a wholly owned subsidiary of Roche Holding Ltd. Roche Holding Ltd is the indirect beneficial owner of these securities of the Issuer.
The Series B Preferred Stock is convertible into Common Stock on a 5.0994-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
/s/ Beat Kraehenmann, authorized signatory
2020-07-16
/s/ Claudia Boeckstiegel, authorized signatory
2020-07-16